Literature DB >> 23747666

[Plasma cholinesterase activity in hepatic diseases].

Manel Araoud1, Hamida Mhenni, Ilhem Hellara, Olfa Hellara, Fadoua Neffati, Wahiba Douki, Marwa Mili, Hammouda Saffar, Mohamed Fadhel Najjar.   

Abstract

Plasma cholinesterase activity (ChE) may vary in some pathological circumstances. We studied the changes in activity of this enzyme according to the type of liver injury, to assess the interest of this parameter in the diagnosis of liver diseases. Our study was performed on 102 patients with different liver diseases and 53 healthy controls. The ChE activity was lower in patients compared to control group (p < 0.0001), and more pronounced in cirrhotic patients compared to those suffering from hepatitis. Elevated activities of AST, ALT, GGT and ALP and bilirubinemia, and decreased albuminemia were noted in patients compared to controls (p < 0.001). Hypoalbuminemia was significantly important in cirrhotic patients compared to those suffering from cholestasis or hepatitis. A correlation between ChE and bilirubin, albumin and serum protein was found in patients with cirrhosis or those with chronic hepatitis. A significantly lower activity of ChE was found in patients with hepatic insufficiency (HI). In case of suspicion of HI, the prescription of ChE activity could guide or confirm the diagnosis of the impairment.

Entities:  

Keywords:  cholestasis; cirrhosis; hepatitis; hepatocellular deficiency; plasma cholinesterase

Mesh:

Substances:

Year:  2013        PMID: 23747666     DOI: 10.1684/abc.2013.0819

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  1 in total

1.  Decreased activity of butyrylcholinesterase in blood plasma of patients with chronic obstructive pulmonary disease.

Authors:  Paulina Sicinska; Bozena Bukowska; Aneta Pajak; Aneta Koceva-Chyla; Tadeusz Pietras; Piotr Nizinkowski; Paweł Gorski; Maria Koter-Michalak
Journal:  Arch Med Sci       Date:  2016-06-20       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.